[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571297":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":50,"collaborators":26,"id":54,"slug":26,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":26,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":26,"enrollmentInfo":62,"targetDuration":26,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Menoufia University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Fertitonex group","ACTIVE_COMPARATOR","Patients in this group will receive Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.",[13],"Drug: Fertitonex capsule",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","Patients in this group will receive placebo capsule twice daily for 3 months.",[19],"Drug: Placebo Oral Capsule",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Fertitonex capsule","Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo Oral Capsule","placebo oral capsule. the dose is twice daily for 3 months",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Ammar F Alorabi","CONTACT","+201067608011","ammar.alorabi95@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"cosmosGeoPoint":26,"geoPoint":26,"contacts":45},"Menoufia Faculty of Medicine","RECRUITING","Shebin El-Kom","Menoufia","32511","Egypt",[46],{"name":47,"role":34,"phone":48,"phoneExt":26,"email":49},"Mustafa F Doctor","+201557586188","Moustafa.fathy@med.menofia.edu.eg",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Ammar Fathi Mohamed AlOrabi","Doctor","100571297",false,"NCT06718426","Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient.","Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient, Placebo Controlled Study","Inclusion Criteria:\n\n* Primary infertility.\n* Abnormal semen analysis parameters.\n* Clinically evident varicocele confirmed by scrotal duplex.\n\nExclusion Criteria:\n\n* 2ry infertility.\n* Normal semen analysis parameters.\n* Clinically non-evident varicocele.\n* Past history of varicocelectomy.","MALE","18 Years",{"count":63,"type":64},110,"ESTIMATED","INTERVENTIONAL",[67],"NA","The aim of the study is to evaluate the Fertitonex effects on semen parameters in clinical varicocele patients.",[70],"Varicocele",[72,73,74,75],"varicocele","Fertitonex","infertility","semen analysis","2025-03-23",{"date":78,"type":79},"2025-03-26","ACTUAL",{"date":81,"type":79},"2024-12-01",{"date":83,"type":64},"2026-02-01",{"name":5,"class":6},1]